Tenax Therapeutics

NEWS

Business

BioSpace Movers & Shakers, Feb. 4

Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.

February 3, 2022

9 min read

Alex Keown

Business

New CEOs Named at Two Biopharma Companies

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

July 8, 2021

2 min read

Vanessa Doctor, RN

IN THE PRESS

Bio NC

Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs

January 4, 2022

9 min read

Business

Tenax Therapeutics Reports Third Quarter 2021 Results and Provides Business Update

November 16, 2021

9 min read

FDA

Tenax Therapeutics Announces Clearance of the Investigational New Drug Application for Imatinib in Pulmonary Arterial Hypertension (PAH)

October 6, 2021

7 min read

Bio NC

Tenax Therapeutics to Present at the Benzinga Healthcare Small Cap Conference

September 28, 2021

5 min read

Bio NC

Tenax Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 9, 2021

3 min read

Business

Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update

August 17, 2021

9 min read

Drug Development

Tenax Announces New Publication Highlighting Novel Levosimendan Mechanism of Action in Pulmonary Hypertension Patients with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

August 12, 2021

7 min read

Bio NC

Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

August 5, 2021

5 min read

Deals

Tenax Therapeutics Announces CEO Transition and $10 Million PIPE Offering Priced At-the-Market under Nasdaq Rules

July 7, 2021

8 min read

Business

Tenax Therapeutics Set to Join Russell Microcap® Index

June 10, 2021

6 min read

JOBS